Company: DMAC
Filing Date: 2025-05-15
Form Type: 8-K
Source: 0001437749-25-017239
Chunk: 1

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-05-15
Form: 8-K
Item: Item 5.07
Chunk 1
---
12,396,835  
  Charles Semba, M. D.           6,728,825             218,530            12,396,835  

Voting Proposal Two - Appointment of Independent Registered Public Accounting Firm and Authorization to Fix Remuneration.

The voting proposal to appoint Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025 and authorize the Board to fix the Company’s independent registered public accounting firm’s remuneration was approved by the following final voting results:

   Votes For      Votes Withheld      Broker Non-Votes  
 ────────────────────────────────────────────────────────
  18,475,360             868,830                     0  

Voting Proposal Three - Advisory Approval of Executive Compensation

The voting proposal to approve, on an advisory (non-binding) basis, the Company’s executive compensation was approved by the following final voting results:

  Votes For      Votes Against      Abstain      Broker Non-Votes  
 ───────────────────────────────────────────────────────────────────
  6,536,608            398,959       11,788            12,396,835  

Item 9.01Financial Statements and Exhibits.